The presence of CXCL16 derived from glioma cells was observed to promote tumor invasion and proliferation through a chemokine receptor that binds the soluble form of CXCL16, C-X-C chemokine receptor 6 (CXCR6) [78]. Here, CXCR6 is linked to central nervous system cancer.